| RYEAX | VGENX | RYEAX / VGENX | |
| Total Expense Ratio | 1.62 | 0.45 | 360% |
| Annual Report Gross Expense Ratio | 1.67 | 0.45 | 371% |
| Fund Existence | 28 years | 42 years | - |
| Gain YTD | 25.797 | 14.605 | 177% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 44.9M | 6.91B | 1% |
| Annual Yield % from dividends | 2.34 | 2.84 | 82% |
| Returns for 1 year | 31.61 | 16.91 | 187% |
| Returns for 3 years | 38.32 | 22.50 | 170% |
| Returns for 5 years | 111.87 | 56.11 | 199% |
| Returns for 10 years | 62.59 | 13.87 | 451% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FFIMX | 23.59 | 0.12 | +0.52% |
| Fidelity Advisor Asset Manager 50% I | |||
| MGRFX | 17.24 | N/A | N/A |
| MassMutual Mid Cap Growth R5 | |||
| THPBX | 25.82 | N/A | N/A |
| BNY Mellon Balanced Opportunity J | |||
| TISVX | 19.41 | N/A | N/A |
| Transamerica International Sm Cp Val I | |||
| LYFCX | 18.66 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||